UCB

Call to US-based HCPs.   UCB is supporting a training opportunity for current rheumatology fellows focusing in women's health. Click the link below to apply. 

Sometimes the best skill isn't technical at all. As we reflect on World Youth Skills Day, Jette Jellinghaus, our Dual Student in Germany working in Marketing, has discovered that staying open to everything changes how you learn. Her willingness to ask questions and connect with knowledgeable people around UCB shows how curiosity becomes the foundation for growth. When you're eager to learn, there's always more to discover.  https://lnkd.in/eujP7JdD #WorldYouthSkillsDay #MakeYourMarkForPatients #TeamUCB #PharmaJobs

📈 #UCBusinessUpdate 📈 With continued and sustainable growth - rooted in our commitment to deliver and our confidence in the future - we’re purposefully delivering innovative solutions for people living with severe diseases. 🎯 At the half-year mark, we’re reporting on our financial and extra-financial progress, writing a story of consistent execution of our innovation-driven strategy. 🚀 We’re proud of #TeamUCB’s achievements in the first six months, and we’re using that momentum to propel us into the second half of the year. #InspiredByPatients #DrivenByScience

🎧 Podcast alert! Marie Teil has been featured on the latest episode of “Women’s Health Uncovered” sharing the personal and professional journey behind UCB’s women of childbearing age program. Marie says, “When UCB asked me how we could improve data for women of childbearing age, I was thrilled to be able to contribute to a topic that dear to my heart. We started small, but with a clear goal: to generate the data women need to make informed decisions during their reproductive health journey.” We remain committed to advancing science that reflects the realities of patients who have historically been left out of research. By listening, learning, and innovating together, we’re working to close the gender data gap and shape a more inclusive future for women’s health. Listen now: http://bit.ly/4llrsWu

Yesterday, we celebrated World Youth Skills Day and the early talent starting their careers and making their mark at UCB.  While World Youth Skills Day 2025 focuses on AI and digital skills, our apprentices, dual students, and graduates are discovering that curiosity, collaboration, and adaptability are also crucial skills for meaningful work. Over the coming weeks, we'll share their stories. What skills do you think are most valuable for early talent? Let us know in the comments. https://lnkd.in/eujP7JdD   #MakeYourMarkForPatients #TeamUCB #PharmaJobs #EarlyCareers

At #EPNS2025, we presented data on the disease course of thymidine kinase 2 deficiency (#TK2d), providing insights into the disease's progressive nature. By deepening our understanding of TK2d’s progression, we aim to inform better supportive care strategies for people with the disease.  Our findings underscore the severe burden that TK2d places on those living with the disease and their families, and the necessity for ongoing research and innovation to identify and address unmet needs. As we continue to explore new frontiers in TK2d research, UCB remains focused on delivering impactful solutions that hopefully improve quality of life. Learn more from Cristy Balcells here: https://lnkd.in/eGN-Bh8A #RareDiseaseAwareness 

For those living with Dravet syndrome, the challenges are about more than seizures. Our research presented at #EPNS includes evaluations of non-seizure burdens in Dravet syndrome in pediatric and adult patients. At UCB, we are committed to addressing unmet needs and uncovering new opportunities to improve outcomes - beyond seizures - for people living with developmental and epileptic encephalopathies (DEEs).  Learn More about UCB Neurology: https://lnkd.in/ed_52kSt

Thymidine kinase 2 deficiency (#TK2d) is an ultra-rare, life-threatening, genetic mitochondrial disease that is characterized by progressive and severe muscle weakness that can become worse over time. Data from our disease course studies to be presented at #EPNS, shed light on the progression and trajectory of TK2d in patients with age of symptom onset ≤12 years including its impact on motor and respiratory function. At UCB, we are committed to advancing our understanding of TK2d to address the unmet needs of the community. Through innovative approaches, we aim to uncover the full scope of TK2d's impact and pave the way for better care solutions. Learn more here: https://lnkd.in/eGN-Bh8A

The best leaders help you discover what you're truly capable of achieving. Charles Reyserhove embodies this philosophy as our Upstream Biomanufacturing Production Lead. He listens to ideas, connects perspectives, and empowers teams to explore new approaches. His leadership style demonstrates how we harness our collaborative curiosity to drive innovation and meaningful progress. When trust becomes the foundation, extraordinary outcomes follow. #MakeYourMarkForPatients #TeamUCB #PharmaJobs Learn more at UCB Careers https://lnkd.in/dHkyid5y

UCB will present 15 abstracts at #EPNS, underscoring our ongoing commitment to advancing research for people living with neurological conditions.    We look forward to engaging with the neurology community at #EPNS.   Learn More about UCB Neurology. https://lnkd.in/ed_52kSt